YU3400A - Nove soli sa blagotvornim organoleptičkim osobinama - Google Patents

Nove soli sa blagotvornim organoleptičkim osobinama

Info

Publication number
YU3400A
YU3400A YU3400A YU3400A YU3400A YU 3400 A YU3400 A YU 3400A YU 3400 A YU3400 A YU 3400A YU 3400 A YU3400 A YU 3400A YU 3400 A YU3400 A YU 3400A
Authority
YU
Yugoslavia
Prior art keywords
organoleptic properties
new salts
beneficial
beneficial organoleptic
salts
Prior art date
Application number
YU3400A
Other languages
English (en)
Inventor
Laszlo Ledniczky
Istvan Seres
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Publication of YU3400A publication Critical patent/YU3400A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Pronalazak se odnosi na nove soli poznatih lekova koje imaju prijatan ukus.[The invention relates to new salts of known drugs which have pleasant taste.
YU3400A 1997-07-25 1998-07-22 Nove soli sa blagotvornim organoleptičkim osobinama YU3400A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9701293A HUP9701293A3 (en) 1997-07-25 1997-07-25 New salts without unsavoury taste and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
YU3400A true YU3400A (sh) 2002-03-18

Family

ID=89995415

Family Applications (1)

Application Number Title Priority Date Filing Date
YU3400A YU3400A (sh) 1997-07-25 1998-07-22 Nove soli sa blagotvornim organoleptičkim osobinama

Country Status (14)

Country Link
EP (1) EP1003557B1 (sh)
AR (1) AR016540A1 (sh)
AU (1) AU8553598A (sh)
EA (1) EA002719B1 (sh)
EE (1) EE04098B1 (sh)
GE (1) GEP20022613B (sh)
HR (1) HRP20000037A2 (sh)
HU (1) HUP9701293A3 (sh)
PL (1) PL344038A1 (sh)
SK (1) SK284641B6 (sh)
TW (1) TW509569B (sh)
UA (1) UA69390C2 (sh)
WO (1) WO1999004822A2 (sh)
YU (1) YU3400A (sh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10013712A1 (de) * 2000-03-20 2001-09-27 Nutrinova Gmbh Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
US20020081360A1 (en) * 2000-12-27 2002-06-27 Andreas Burgard Salts of L-amino acid having improved taste and their preparation
DE10130504B4 (de) 2001-06-25 2005-02-03 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Xanthin- und Phenazon-Acesulfam-H-Komplexe mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
AU2008334924A1 (en) * 2007-12-12 2009-06-18 Ultimorphix Technolgies B.V. Solid forms of Tenofovir disoproxil
US7935817B2 (en) * 2008-03-31 2011-05-03 Apotex Pharmachem Inc. Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof
CN103664781B (zh) * 2013-12-13 2015-12-09 浙江普洛康裕制药有限公司 盐酸屈他维林晶型i和晶型ii及制备方法
CN103694171B (zh) * 2013-12-13 2016-06-29 浙江普洛康裕制药有限公司 盐酸屈他维林晶型iii和晶型iv及其制备方法
US20240091217A1 (en) * 2022-07-29 2024-03-21 Sushma Paul BERLIA Stable pharmaceutical oral liquid formulation of an antispasmodic agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621917A (sh) *
GB1577196A (en) * 1977-06-03 1980-10-22 Ile De France Compositions containing erythromycin and metoclopramide
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation
FR2636532B1 (fr) * 1988-09-20 1993-11-19 Glaxo Group Ltd Compositions pharmaceutiques

Also Published As

Publication number Publication date
EP1003557B1 (en) 2003-05-02
EP1003557A2 (en) 2000-05-31
SK284641B6 (sk) 2005-08-04
SK1072000A3 (en) 2000-11-07
HRP20000037A2 (en) 2000-10-31
HUP9701293A2 (hu) 1999-02-01
PL344038A1 (en) 2001-09-24
HUP9701293A3 (en) 1999-08-30
HU9701293D0 (en) 1997-09-29
UA69390C2 (uk) 2004-09-15
TW509569B (en) 2002-11-11
AU8553598A (en) 1999-02-16
WO1999004822A2 (en) 1999-02-04
EA002719B1 (ru) 2002-08-29
EE200000049A (et) 2000-10-16
GEP20022613B (en) 2002-01-25
AR016540A1 (es) 2001-07-25
EA200000160A1 (ru) 2000-10-30
WO1999004822A3 (en) 1999-08-12
EE04098B1 (et) 2003-08-15

Similar Documents

Publication Publication Date Title
MY117805A (en) Resorcinol derivatives
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
HK1026606A1 (en) Chair type massage.
ZA200404306B (en) 3'-prodrugs of 2'-deoxy-beta-L-nucleosides.
EP1063990A4 (en) THERAPY FOR ESTROGEN RELATED DISORDERS
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
AU2001245295A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
ZA200108856B (en) Treatment of neurotic disorders.
YU3400A (sh) Nove soli sa blagotvornim organoleptičkim osobinama
CA2362698A1 (en) Resorcinol derivatives
PH31326A (en) Methods of inhibiting breast disorders.
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
GB9808022D0 (en) Improvements relating to the delivery of beverages
ZA200109206B (en) Preparation of substituted piperidin-4-ones.
AU2001238493A1 (en) Methods and compositions for the identification, assessment, prevention and therapy of human cancers
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
MX9704341A (es) Producto alimenticio para el consumo humano o animal y un procedimiento para su preparacion.
BG106031A (en) Prucalopride oral solution
HK1040191A1 (zh) 具有改良味道的藥物組合物
HUP9900701A3 (en) Cooking aid of the bar type
ZA991514B (en) Production of polyamides.
WO1999055859A3 (en) Cd40-interacting and traf-interacting proteins
WO2001082969A3 (fr) Medicaments destines au traitement des pathologies tumorales contenant le compose r05-4864 et un agent inducteur de l'apoptose